Abstract
Patients with asthma uncontrolled on inhaled corticosteroids may benefit from umeclidinium (UMEC), a long-acting muscarinic antagonist. This Phase IIb, double-blind study included patients with reversible, uncontrolled/partially-controlled asthma for ≥6 months, receiving ≥100 mcg/day fluticasone propionate (or equivalent) for ≥12 weeks. Following a 2-week run-in on open-label fluticasone furoate (FF) 100 mcg, patients were randomised (1:1:1) to receive UMEC 31.25 mcg, UMEC 62.5 mcg or placebo on top of FF 100 mcg once-daily for 24 weeks. As-needed salbutamol was provided. Primary and secondary endpoints were change from baseline in clinic trough forced expiratory volume in 1 s (FEV1) and clinic FEV1 3 h post-dose, respectively, at Week 24. Other endpoints included change from baseline in home daily spirometry (trough FEV1, evening FEV1, morning [pre-dose] and evening peak expiratory flow) over 24 weeks. Safety was assessed throughout the study. The intent-to-treat population comprised 421 patients (UMEC 31.25 mcg: n =139, UMEC 62.5 mcg: n =139, placebo: n =143). UMEC 31.25 mcg and 62.5 mcg demonstrated significantly greater improvements from baseline in clinic trough FEV1 at Week 24 (difference [95% CI]: 0.176 L [0.092, 0.260; ...Continue Reading
References
Jan 1, 1994·Journal of Clinical Epidemiology·E F JuniperL E Griffith
Apr 9, 2002·The European Respiratory Journal·P W Jones
Apr 13, 2005·Respiratory Medicine·Elizabeth F JuniperElisabeth Ståhl
Dec 2, 2006·COPD·Paul W Jones
Dec 2, 2006·COPD·James F Donohue
Sep 28, 2007·Proceedings of the National Academy of Sciences of the United States of America·Prescott G WoodruffJohn V Fahy
Jul 18, 2008·Respiratory Medicine·Marcelo B MenezesElcio O Vianna
Jun 19, 2009·American Journal of Respiratory and Critical Care Medicine·Helen K ReddelUNKNOWN American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations
Oct 29, 2010·The New England Journal of Medicine·Stephen P PetersUNKNOWN National Heart, Lung, and Blood Institute Asthma Clinical Research Network
Jun 4, 2011·The Journal of Allergy and Clinical Immunology·Huib A M KerstjensJan A van Noord
Mar 2, 2012·European Respiratory Review : an Official Journal of the European Respiratory Society·P DemolyL Adamek
Sep 4, 2012·The New England Journal of Medicine·Huib A M KerstjensEric D Bateman
Oct 3, 2012·Respiratory Physiology & Neurobiology·Marc DecramerGlenn Crater
Oct 3, 2013·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Stanley M FinkelsteinArin VanWormer
Nov 21, 2013·Thorax·Eric D BatemanAshley Woodcock
Mar 7, 2014·Thorax·N K LeidyS Sethi
Sep 13, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Eugene R BleeckerEric D Bateman
Oct 8, 2014·Respiratory Research·Nancy K LeidySanjay Sethi
Dec 3, 2014·Respiratory Medicine·Laurie A LeeSteven Pascoe
Feb 14, 2015·Respiratory Medicine·J Christian VirchowHanne H Villesen
Feb 16, 2015·The Lancet. Respiratory Medicine·Huib A M KerstjensEric D Bateman
Apr 30, 2015·American Journal of Respiratory and Critical Care Medicine·Elizabeth A BelloliVibha N Lama
Apr 19, 2016·American Journal of Respiratory and Critical Care Medicine·Anne-Marie RussellToby M Maher
Apr 28, 2016·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Gustavo J Rodrigo, Vicente Plaza
Aug 22, 2017·The Lancet. Respiratory Medicine·UNKNOWN GBD 2015 Chronic Respiratory Disease Collaborators
Sep 28, 2017·Respiratory Medicine·Laurie LeeSteven Pascoe
Jun 4, 2019·Respiratory Research·Linda M NelsenNancy K Leidy